| DIRECT COMPETITOR COMPARISON | |
| NVD | Pvt1 | GNBT | Pvt2 | Industry | | Market Cap: | 9.62M | N/A | 135.82M | N/A | 72.42M | | Employees: | 10 | 53,1001 | 43 | N/A | 43 | | Qtrly Rev Growth (yoy): | 114.40% | N/A | 67.10% | N/A | 3.00% | | Revenue (ttm): | 459.00K | 20.81B1 | 1.12M | N/A | 17.49M | | Gross Margin (ttm): | N/A | N/A | 52.82% | N/A | 71.29% | | EBITDA (ttm): | -6.27M | N/A | -25.45M | N/A | -6.12M | | Oper Margins (ttm): | -1,451.85% | N/A | -2,347.43% | N/A | -3.79% | | Net Income (ttm): | -7.11M | N/A | -45.81M | N/A | N/A | | EPS (ttm): | -0.118 | N/A | -0.317 | N/A | -0.19 | | P/E (ttm): | N/A | N/A | N/A | N/A | 16.20 | | PEG (5 yr expected): | N/A | N/A | N/A | N/A | 1.31 | | P/S (ttm): | 20.95 | N/A | 121.43 | N/A | 3.30 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.85 | 0.00% | 57.54B | 12.40 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.18 | 0.00% | 13.93B | 16.12 | | Genzyme Corp. | GENZ | 49.98 | 0.00% | 13.26B | 28.49 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.59 | 0.00% | 41.93B | 18.02 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.64 | 0.00% | 9.03B | 1033.47 | | Teva Pharmaceutical Industries Limited | TEVA | 54.01 | 0.00% | 47.58B | 49.41 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.90 | 0.00% | 4.02B | 19.54 | | King Pharmaceuticals Inc. | KG | 11.72 | 0.00% | 2.91B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.99 | 0.00% | 5.50B | 110.37 | | Pfizer Inc. | PFE | 18.49 | 0.00% | 149.21B | 15.36 | | Johnson & Johnson | JNJ | 64.36 | 0.00% | 177.58B | 14.06 | | GlaxoSmithKline plc | GSK | 42.75 | 0.00% | 108.37B | 13.49 | | Sanofi-Aventis | SNY | 39.38 | 0.00% | 102.83B | N/A | | Novartis AG | NVS | 55.55 | 0.00% | 126.17B | 16.63 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.42 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 46.30 | 0.00% | 67.13B | 9.30 | | Abbott Laboratories | ABT | 53.78 | 0.00% | 83.18B | 14.57 | | Bristol-Myers Squibb Co. | BMY | 25.14 | 0.00% | 49.80B | 13.01 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|